New mRNA vaccine aims to help immune system fight advanced cancers
NCT ID NCT07363369
Summary
This early-stage study is testing a new type of mRNA vaccine designed to target a specific protein (FAP) found in the supportive tissue around tumors. The goal is to see if the vaccine, given with standard immunotherapy drugs, is safe and can help the immune system attack advanced solid tumors like lung or colorectal cancer. It will enroll a small group of adults whose cancer has not responded to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.